Wednesday, November 4, 2026Eastern Time · Updated through the dayRSS

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Apothecary Pharma Recalls Compounded Tirzepatide, NAD+

MH

By Maren Holt · Senior Reporter, GLP-1

Nov 4 10:47 ETSource: American Spa

From the source

Apothecary Pharma Recalls Compounded Tirzepatide, NAD+

Read at americanspa.com

Source URL https://www.americanspa.com/medical-spa/apothecary-pharma-recalls-compounded-tirzepatide-nad

Prescribed peptides from $99/moSee all →